At the onset of adopting decentralised clinical trial (DCT) models, sponsors and sites prioritise the integration of electronic clinical outcome assessments (eCOAs) as essential tools.
Over the past few years, many clinical study administrators wanted to use the bring your own device (BYOD) model within their eCOA, but they were typically constrained by regulatory require
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS